Processa Pharmaceuticals (PCSA) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
PCSA is expected to report earnings to rise 25.00% to -10 cents per share on March 28
Q4'23
Est.
$-0.10
Q3'23
Beat
by $0.02
Q2'23
Beat
by $0.05
Q1'23
Beat
by $0.05
Q4'22
Missed
by $0.49
The last earnings report on November 08 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 35.56K shares outstanding, the current market capitalization sits at 3.30M.